<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>Variant Creutzfeldt-Jakob Disease</title></head><body><div><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Written Evidence submitted by Dr Roland Salmon (CJD0002)</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">What do you consider to be the likely prevalence of subclinical </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">vCJD</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold"> infection in the UK population? What evidence is there to support this </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">view?</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The likely prevalence of subclinical v CJD infection in the UK plausibly lies between 282 and 692 per million of the resident population.  These figures represent the area of overlap of the 95% confidence intervals of the two published </span><span style="font-family:'Times New Roman'; font-size:11pt">surveys</span><span style="font-family:'Times New Roman'; font-size:11pt"> (1,2),</span><span style="font-family:'Times New Roman'; font-size:11pt"> both of which</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">examined</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">ab</span><span style="font-family:'Times New Roman'; font-size:11pt">normal </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> protein deposition in</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">archived </span><span style="font-family:'Times New Roman'; font-size:11pt">appendix </span><span style="font-family:'Times New Roman'; font-size:11pt">tissue from </span><span style="font-family:'Times New Roman'; font-size:11pt">surgical operations to remove the appendix</span><span style="font-family:'Times New Roman'; font-size:11pt">, performed in</span><span style="font-family:'Times New Roman'; font-size:11pt"> various</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt"> UK hospitals</span><span style="font-family:'Times New Roman'; font-size:11pt">.  </span><span style="font-family:'Times New Roman'; font-size:11pt">This is roughly equivalent to between 1 in 1,000 and 1 in 4,000 people and </span><span style="font-family:'Times New Roman'; font-size:11pt">combining the central estimates f</span><span style="font-family:'Times New Roman'; font-size:11pt">rom the two studies</span><span style="font-family:'Times New Roman'; font-size:11pt">, suggests</span><span style="font-family:'Times New Roman'; font-size:11pt"> that about 25,000 </span><span style="font-family:'Times New Roman'; font-size:11pt">people </span><span style="font-family:'Times New Roman'; font-size:11pt">have become</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">“</span><span style="font-family:'Times New Roman'; font-size:11pt">infected</span><span style="font-family:'Times New Roman'; font-size:11pt">”.</span><span style="font-family:'Times New Roman'; font-size:11pt">  </span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 10pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">It is legitimate to ask whether abnormal </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> protein</span><span style="font-family:'Times New Roman'; font-size:11pt"> deposition in the appendix is </span><span style="font-family:'Times New Roman'; font-size:11pt">simply a non-specific finding.  After all there are no a</span><span style="font-family:'Times New Roman'; font-size:11pt">ppendix surveys from populations that had not been exposed to BSE.  To try and answer this,</span><span style="font-family:'Times New Roman'; font-size:11pt"> examination of </span><span style="font-family:'Times New Roman'; font-size:11pt">appendicectomy</span><span style="font-family:'Times New Roman'; font-size:11pt"> tissue from</span><span style="font-family:'Times New Roman'; font-size:11pt"> operations carried out in</span><span style="font-family:'Times New Roman'; font-size:11pt"> the 1970s and earlier</span><span style="font-family:'Times New Roman'; font-size:11pt"> (which pre-dates the appearance of</span><span style="font-family:'Times New Roman'; font-size:11pt"> BSE</span><span style="font-family:'Times New Roman'; font-size:11pt">) </span><span style="font-family:'Times New Roman'; font-size:11pt">is</span><span style="font-family:'Times New Roman'; font-size:11pt"> being carried out</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">How might th</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">is subclinical infection rate translate to future cases of </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">vCJD</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">? What are the key uncertainties in the relationship between subclinical and clinical </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">vCJD</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">?</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">There are key differences between the sub-clinical cases identified in the appendix surveys and the </span><span style="font-family:'Times New Roman'; font-size:11pt">177</span><span style="font-family:'Times New Roman'; font-size:11pt"> clinical cases of v CJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> identified in the UK to date. </span><span style="font-family:'Times New Roman'; font-size:11pt">v</span><span style="font-family:'Times New Roman'; font-size:11pt">CJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> clinical cases in the UK have a modal age at death of 28</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">years, </span><span style="font-family:'Times New Roman'; font-size:11pt">something, surprisingly, that has not altered through the whole course of the epidemic.  They </span><span style="font-family:'Times New Roman'; font-size:11pt">are diagnosed more frequently in th</span><span style="font-family:'Times New Roman'; font-size:11pt">e North and in Scotland and confirmed cases have all been </span><span style="font-family:'Times New Roman'; font-size:11pt">methionine</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">homozygotes</span><span style="font-family:'Times New Roman'; font-size:11pt"> (MM) at </span><span style="font-family:'Times New Roman'; font-size:11pt">codon</span><span style="font-family:'Times New Roman'; font-size:11pt"> 129 of the gene coding for </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> protein</span><span style="font-family:'Times New Roman'; font-size:11pt"> (</span><span style="font-family:'Times New Roman'; font-size:11pt">3</span><span style="font-family:'Times New Roman'; font-size:11pt">).</span><span style="font-family:'Times New Roman'; font-size:11pt">  By contrast,</span><span style="font-family:'Times New Roman'; font-size:11pt"> in</span><span style="font-family:'Times New Roman'; font-size:11pt"> the</span><span style="font-family:'Times New Roman'; font-size:11pt"> appendix surveys</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">the</span><span style="font-family:'Times New Roman'; font-size:11pt">re is</span><span style="font-family:'Times New Roman'; font-size:11pt"> no p</span><span style="font-family:'Times New Roman'; font-size:11pt">articularly affected age group or </span><span style="font-family:'Times New Roman'; font-size:11pt">region</span><span style="font-family:'Times New Roman'; font-size:11pt"> of the UK and although</span><span style="font-family:'Times New Roman'; font-size:11pt"> 50% of the samples </span><span style="font-family:'Times New Roman'; font-size:11pt">also </span><span style="font-family:'Times New Roman'; font-size:11pt">were MM </span><span style="font-family:'Times New Roman'; font-size:11pt">homozygotes</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> like the clinical cases,</span><span style="font-family:'Times New Roman'; font-size:11pt"> the other 50% were more or less equally split between VV </span><span style="font-family:'Times New Roman'; font-size:11pt">homozygotes</span><span style="font-family:'Times New Roman'; font-size:11pt"> and </span><span style="font-family:'Times New Roman'; font-size:11pt">heterozygotes</span><span style="font-family:'Times New Roman'; font-size:11pt"> (MV) (2)</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">All this suggests that sufficiently little is known about the natural history of infection with this agent, that any attempt to translate this subclinical infection rate to future cases of v CJD will </span><span style="font-family:'Times New Roman'; font-size:11pt">need to </span><span style="font-family:'Times New Roman'; font-size:11pt">make a number of assumptions.</span><span style="font-family:'Times New Roman'; font-size:11pt">  </span><span style="font-family:'Times New Roman'; font-size:11pt">Mathematical m</span><span style="font-family:'Times New Roman'; font-size:11pt">ode</span><span style="font-family:'Times New Roman'; font-size:11pt">llers at Imperial College, London, have simulated this</span><span style="font-family:'Times New Roman'; font-size:11pt"> (4)</span><span style="font-family:'Times New Roman'; font-size:11pt"> and predict “a potentially long but uncertain tail</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the epidemic, </span><span style="font-family:'Times New Roman'; font-size:11pt">with a peak annual incidence</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the future</span><span style="font-family:'Times New Roman'; font-size:11pt"> of around 11 cases” (95% confidence intervals 1-65 case)</span><span style="font-family:'Times New Roman'; font-size:11pt"> occurring between 2020 and 20</span><span style="font-family:'Times New Roman'; font-size:11pt">35 and this second wave</span><span style="font-family:'Times New Roman'; font-size:11pt"> of</span><span style="font-family:'Times New Roman'; font-size:11pt"> cases lasting until around the year 2080</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> A key assumption that they make is that individuals that are either VV </span><span style="font-family:'Times New Roman'; font-size:11pt">homozygotes</span><span style="font-family:'Times New Roman'; font-size:11pt"> or </span><span style="font-family:'Times New Roman'; font-size:11pt">heterozygotes</span><span style="font-family:'Times New Roman'; font-size:11pt"> are not </span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 10pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">more susceptible to infection tha</span><span style="font-family:'Times New Roman'; font-size:11pt">n MM </span><span style="font-family:'Times New Roman'; font-size:11pt">homozygotes</span><span style="font-family:'Times New Roman'; font-size:11pt">.  Although, as a working</span><span style="font-family:'Times New Roman'; font-size:11pt"> assumption</span><span style="font-family:'Times New Roman'; font-size:11pt">, this</span><span style="font-family:'Times New Roman'; font-size:11pt"> is inherently reasonable, given the complexity of the genetics of </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> diseases</span><span style="font-family:'Times New Roman'; font-size:11pt"> and the identification of other genetic loci that may modify susceptibility to v CJD (5), this assumption cannot be taken as a given.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">What are the likely rou</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">tes of infection for </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">vCJD</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">? How have the potential modes of transmission changed over time?</span></p><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Given</span><span style="font-family:'Times New Roman'; font-size:11pt"> that the </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> implicated in </span><span style="font-family:'Times New Roman'; font-size:11pt">v</span><span style="font-family:'Times New Roman'; font-size:11pt">CJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> has been demonstrated to be identical to that of BSE (6,7) (and, indeed to that of the spongiform encephalopathy of cats, Fel</span><span style="font-family:'Times New Roman'; font-size:11pt">ine Spongiform Encephalopathy or FSE) it </span><span style="font-family:'Times New Roman'; font-size:11pt">is likely </span><span style="font-family:'Times New Roman'; font-size:11pt">that most cases to date have resulted from eating contaminated beef.</span><span style="font-family:'Times New Roman'; font-size:11pt">  This is the epidem</span><span style="font-family:'Times New Roman'; font-size:11pt">ic of v CJD that, to date, has </span><span style="font-family:'Times New Roman'; font-size:11pt">peaked in 2000 and declined such that only one case has been recorded in the last two </span><span style="font-family:'Times New Roman'; font-size:11pt">years.  It was brought under control by the exclusion of certain specified bovine </span><span style="font-family:'Times New Roman'; font-size:11pt">offals</span><span style="font-family:'Times New Roman'; font-size:11pt"> from the food chain in 1989</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> with the measures reinforced in 1996.   </span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="7" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">In addition </span><span style="font-family:'Times New Roman'; font-size:11pt">vCJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> has been secondarily transmitted from human to human via blood</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> with 3 clinical cases and 2 asymptomatic infections described in the published scientific literature (8)</span><span style="font-family:'Times New Roman'; font-size:11pt">.  </span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="8" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Finally </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> infectivity is notoriously difficult to inactivate fully. S</span><span style="font-family:'Times New Roman'; font-size:11pt">poradic CJD (the “usual” type of CJD)  had been demonstrated to be transm</span><span style="font-family:'Times New Roman'; font-size:11pt">issible by neurosurgery in case studies published as long ago as 1974 so, although it has not been unequivocally demonstrated, to da</span><span style="font-family:'Times New Roman'; font-size:11pt">te, it has to be assumed that </span><span style="font-family:'Times New Roman'; font-size:11pt">v</span><span style="font-family:'Times New Roman'; font-size:11pt">CJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> can also potentially be transmitted from patient by contaminated surgical instruments.  A</span><span style="font-family:'Times New Roman'; font-size:11pt">lso, unlike infectivity in sporadic CJD which is substantially confined to the Central N</span><span style="font-family:'Times New Roman'; font-size:11pt">ervous System, infectivity in </span><span style="font-family:'Times New Roman'; font-size:11pt">v</span><span style="font-family:'Times New Roman'; font-size:11pt">CJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> can also be found in peripheral </span><span style="font-family:'Times New Roman'; font-size:11pt">lymphoreticular</span><span style="font-family:'Times New Roman'; font-size:11pt"> tissue (hence the strategy of studying </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> deposition in archived appendix tissue).</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="9" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 10pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Going forward</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> new incidents of</span><span style="font-family:'Times New Roman'; font-size:11pt"> transmission from diet should</span><span style="font-family:'Times New Roman'; font-size:11pt"> not be occurring</span><span style="font-family:'Times New Roman'; font-size:11pt">, although it must be remembered that cases resulting from dietary exposure in the past but with longer incubation periods, say as a result of different genetic susceptibility,</span><span style="font-family:'Times New Roman'; font-size:11pt"> will continue to occur</span><span style="font-family:'Times New Roman'; font-size:11pt">.  However, given the estimated prevalence of infection (above)</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">there remains </span><span style="font-family:'Times New Roman'; font-size:11pt">the </span><span style="font-family:'Times New Roman'; font-size:11pt">ongoing </span><span style="font-family:'Times New Roman'; font-size:11pt">risk of person-to-person transmission from blood components, blood products and surgery.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">What procedures are currently in place to monitor, </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">control and prevent further spread of </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">vCJD</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold"> across the UK population? What more could b</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">e done to reduce the risk pose</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">d </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">by </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">vCJD</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">?</span></p><ol start="10" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Monitoring</span><span style="font-family:'Times New Roman'; font-size:11pt"> of </span><span style="font-family:'Times New Roman'; font-size:11pt">vCJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> remains the responsibility of the National CJD Research and Surveillance Unit, now part of Edinburgh University and established in </span><span style="font-family:'Times New Roman'; font-size:11pt">May </span><span style="font-family:'Times New Roman'; font-size:11pt">1990 precisely to identify whether there w</span><span style="font-family:'Times New Roman'; font-size:11pt">ould be</span><span style="font-family:'Times New Roman'; font-size:11pt"> human health consequences of the BSE epidemic.  This they achi</span><span style="font-family:'Times New Roman'; font-size:11pt">eved in 1996 with the identification of the first cases of v CJD.  Essentially cases are reported to the unit by physicians (mostly neurologists) and the cases are then visited by doctors from the unit who help with the confirmation of the diagnosis and co</span><span style="font-family:'Times New Roman'; font-size:11pt">llect certain risk factor information.  The clinical basis of the reporting does pre-suppose that, going forward, the clinical presentation in individuals with other genotypes will resemble that seen in the </span><span style="font-family:'Times New Roman'; font-size:11pt">v CJD </span><span style="font-family:'Times New Roman'; font-size:11pt">cases to date. </span><span style="font-family:'Times New Roman'; font-size:11pt"> If cases were occurring in </span><span style="font-family:'Times New Roman'; font-size:11pt">an older population with symptoms that resembled more closely other senile dementias, then the current surveillance would have more difficulty detecting them.</span><span style="font-family:'Times New Roman'; font-size:11pt"> Ideally, supplementing this scheme with a greater degree of systematic surveillance based on the </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">post mortem</span><span style="font-family:'Times New Roman'; font-size:11pt"> examination of brain tissue would be desirable </span><span style="font-family:'Times New Roman'; font-size:11pt">but is handicapped by declining </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">post mortem </span><span style="font-family:'Times New Roman'; font-size:11pt">rates.  It is very regrettable, in this regard, that discussions with coroners, to try and get them to introduce brain examination systematically into </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">po</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">st mortems </span><span style="font-family:'Times New Roman'; font-size:11pt">carried out at their instruction, have foundered.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="11" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Control </span><span style="font-family:'Times New Roman'; font-size:11pt">has primarily resulted from the slaughter and disposal of </span><span style="font-family:'Times New Roman'; font-size:11pt">BSE-</span><span style="font-family:'Times New Roman'; font-size:11pt">affected cattle</span><span style="font-family:'Times New Roman'; font-size:11pt">, from prohibiting meat and bone meal derived from animal carcasses being fed back to cattle</span><span style="font-family:'Times New Roman'; font-size:11pt"> and </span><span style="font-family:'Times New Roman'; font-size:11pt">from preventing those parts of all </span><span style="font-family:'Times New Roman'; font-size:11pt">cattle</span><span style="font-family:'Times New Roman'; font-size:11pt"> most likely to be infected (essentially brain, spinal cord including the dorsal root ganglion and parts of the small intestine) from entering the </span><span style="font-family:'Times New Roman'; font-size:11pt">human </span><span style="font-family:'Times New Roman'; font-size:11pt">food chain.  The number of affected cattle has declined f</span><span style="font-family:'Times New Roman'; font-size:11pt">rom a peak</span><span style="font-family:'Times New Roman'; font-size:11pt"> of 36,000 cases in 1992 to </span><span style="font-family:'Times New Roman'; font-size:11pt">3 in 2012</span><span style="font-family:'Times New Roman'; font-size:11pt"> (</span><span style="font-family:'Times New Roman'; font-size:11pt">9</span><span style="font-family:'Times New Roman'; font-size:11pt">)</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt">  These measures mostly remain in place.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="12" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; margin:0pt 0pt 0pt 36pt; orphans:0; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Control </span><span style="font-family:'Times New Roman'; font-size:11pt">of secondary spread required</span><span style="font-family:'Times New Roman'; font-size:11pt"> a number of steps to secure the blood supply: (removal of white blood cells from blood to reduce infectivity, exclusion of ce</span><span style="font-family:'Times New Roman'; font-size:11pt">rtain donors believed to be at higher risk of being infectious and sourcing of blood products from outside the UK).   Measures are also in place to reduce the risk of horizontal transmission by surgical instruments (</span><span style="font-family:'Times New Roman'; font-size:11pt">1</span><span style="font-family:'Times New Roman'; font-size:11pt">0</span><span style="font-family:'Times New Roman'; font-size:11pt">).</span><span style="font-family:'Times New Roman'; font-size:11pt">  These include identifying individuals </span><span style="font-family:'Times New Roman'; font-size:11pt">“</span><span style="font-family:'Times New Roman'; font-size:11pt">at</span><span style="font-family:'Times New Roman'; font-size:11pt"> increased</span><span style="font-family:'Times New Roman'; font-size:11pt"> risk</span><span style="font-family:'Times New Roman'; font-size:11pt">”</span><span style="font-family:'Times New Roman'; font-size:11pt">, using dedicated instrument sets to operate on them for operations on tissues likely </span><span style="font-family:'Times New Roman'; font-size:11pt">to contain </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> deposi</span><span style="font-family:'Times New Roman'; font-size:11pt">tion, keeping instruments in sets, more generally and equally, more generally, improving</span><span style="font-family:'Times New Roman'; font-size:11pt"> instrument traceability.</span><span style="font-family:'Times New Roman'; font-size:11pt">  </span><span style="font-family:'Times New Roman'; font-size:11pt"> I</span><span style="font-family:'Times New Roman'; font-size:11pt">ndividuals deemed to be “at increased risk” of CJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> are those</span><span style="font-family:'Times New Roman'; font-size:11pt"> individuals who, broadly, have received blood or been operated on with certain surgical instruments, from someone with CJD and are deemed to have had sufficient proba</span><span style="font-family:'Times New Roman'; font-size:11pt">bility of acquiring the disease thems</span><span style="font-family:'Times New Roman'; font-size:11pt">elves that they could, in their</span><span style="font-family:'Times New Roman'; font-size:11pt"> turn transmit disease via surgery or blood transfusion.  They are thus deferred from blood donation and special arrangements need to be made for surgery that involves tissues in which </span><span style="font-family:'Times New Roman'; font-size:11pt">PrP</span><span style="font-family:'Times New Roman'; font-size:11pt"> infectivity is expected to be found.  Advice from local public health or infection control teams</span><span style="font-family:'Times New Roman'; font-size:11pt"> is recommended</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the first instance and th</span><span style="font-family:'Times New Roman'; font-size:11pt">ose local teams are advised</span><span style="font-family:'Times New Roman'; font-size:11pt"> to seek more expert help, usually via the CJD Section of the National Centre for Infect</span><span style="font-family:'Times New Roman'; font-size:11pt">ious Disease Surveillance and Control of Public Health England that acts as a clearing house for queries and can link them with the UK’s various special</span><span style="font-family:'Times New Roman'; font-size:11pt">ist clinical and research teams such as the </span><span style="font-family:'Times New Roman'; font-size:11pt">National CJD Research and Surveillance Unit</span><span style="font-family:'Times New Roman'; font-size:11pt">, the Medical Res</span><span style="font-family:'Times New Roman'; font-size:11pt">earch Council National </span><span style="font-family:'Times New Roman'; font-size:11pt">Prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> Unit at University College London Institute of Neurology and Great Ormond Street Children’s Hospital.</span></li></ol><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="13" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; margin:0pt 0pt 0pt 36pt; orphans:0; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Reducing the risk further</span><span style="font-family:'Times New Roman'; font-size:11pt"> would</span><span style="font-family:'Times New Roman'; font-size:11pt"> benefit</span><span style="font-family:'Times New Roman'; font-size:11pt"> from easier identification of </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt">-infected individuals. </span><span style="font-family:'Times New Roman'; font-size:11pt">The key requirement here is an appropriate </span><span style="font-family:'Times New Roman'; font-size:11pt">blood test.  Blood tests in specialist settings have been described (1</span><span style="font-family:'Times New Roman'; font-size:11pt">1</span><span style="font-family:'Times New Roman'; font-size:11pt">) but a test (ideally two tests) that could be used widely for dia</span><span style="font-family:'Times New Roman'; font-size:11pt">gnosis and screening remains </span><span style="font-family:'Times New Roman'; font-size:11pt">elusive.</span><span style="font-family:'Times New Roman'; font-size:11pt">  This would, for example, simplify the</span><span style="font-family:'Times New Roman'; font-size:11pt"> task of managing the risk from multiply transfused individuals.  These latter are a </span><span style="font-family:'Times New Roman'; font-size:11pt">heterogenous</span><span style="font-family:'Times New Roman'; font-size:11pt"> group that is difficult to identify from clinical record systems and for whom, the risk posed by any individual, relative to numbers of units received, is unc</span><span style="font-family:'Times New Roman'; font-size:11pt">ertain.</span></li></ol><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="14" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; margin:0pt 0pt 0pt 36pt; orphans:0; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">Finally </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> infectivity remains notoriously difficult finally to inactivate and processes that could be introduced into instrument sterilization on a day to day basis</span><span style="font-family:'Times New Roman'; font-size:11pt"> are still required.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">Other considerations</span></p><ol start="15" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Even though </span><span style="font-family:'Times New Roman'; font-size:11pt">p</span><span style="font-family:'Times New Roman'; font-size:11pt">rion</span><span style="font-family:'Times New Roman'; font-size:11pt"> proteins are </span><span style="font-family:'Times New Roman'; font-size:11pt">ubiquitous in nature</span><span style="font-family:'Times New Roman'; font-size:11pt">, outbreaks of </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> diseases, whether in humans or animals, have always been unexpected</span><span style="font-family:'Times New Roman'; font-size:11pt">.  Quite apart from </span><span style="font-family:'Times New Roman'; font-size:11pt">v</span><span style="font-family:'Times New Roman'; font-size:11pt">CJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> and BSE, other examples include the current unexplained spread of Chronic Wasting Disease of Mule Deer and Elk (CWD) in Nor</span><span style="font-family:'Times New Roman'; font-size:11pt">th America, Transmissible Mink Encephalopathy in America in the 1940s and the extension of sheep </span><span style="font-family:'Times New Roman'; font-size:11pt">scrapie</span><span style="font-family:'Times New Roman'; font-size:11pt"> in Britain in the 1930s (thought</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">retrospectively</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">to</span><span style="font-family:'Times New Roman'; font-size:11pt"> have resulted from contamination of a vaccine developed to protect ag</span><span style="font-family:'Times New Roman'; font-size:11pt">ainst </span><span style="font-family:'Times New Roman'; font-size:11pt">louping</span><span style="font-family:'Times New Roman'; font-size:11pt">-ill, a </span><span style="font-family:'Times New Roman'; font-size:11pt">viral </span><span style="font-family:'Times New Roman'; font-size:11pt">infection of sheep).</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="16" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The replication mechanisms first seen in </span><span style="font-family:'Times New Roman'; font-size:11pt">PrP</span><span style="font-family:'Times New Roman'; font-size:11pt"> have now been identified in other proteins in other common neurodegenerative diseases including </span><span style="font-family:Symbol; font-size:11pt"></span><span style="font-family:Symbol; font-size:11pt"></span><span style="font-family:'Times New Roman'; font-size:11pt">, </span><span style="font-family:'Times New Roman'; font-size:11pt">amyloid</span><span style="font-family:'Times New Roman'; font-size:11pt">-beta</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> in Alzheimer</span><span style="font-family:'Times New Roman'; font-size:11pt">’</span><span style="font-family:'Times New Roman'; font-size:11pt">s disease, </span><span style="font-family:Symbol; font-size:11pt"></span><span style="font-family:'Times New Roman'; font-size:11pt">-</span><span style="font-family:'Times New Roman'; font-size:11pt">synuclein</span><span style="font-family:'Times New Roman'; font-size:11pt"> in </span><span style="font-family:'Times New Roman'; font-size:11pt">Parkinsons’s</span><span style="font-family:'Times New Roman'; font-size:11pt"> Disease</span><span style="font-family:'Times New Roman'; font-size:11pt">, superoxide dis</span><span style="font-family:'Times New Roman'; font-size:11pt">mutase-1 in Amyotrophic Lateral Sclerosis (a form of Motor </span><span style="font-family:'Times New Roman'; font-size:11pt">Neurone</span><span style="font-family:'Times New Roman'; font-size:11pt"> Disease), TDP-43 in Amyotrophic Lateral Sclerosis and </span><span style="font-family:'Times New Roman'; font-size:11pt">frontotemporal</span><span style="font-family:'Times New Roman'; font-size:11pt"> dementia, </span><span style="font-family:'Times New Roman'; font-size:11pt">huntingtin</span><span style="font-family:'Times New Roman'; font-size:11pt"> in Huntington’s Disease</span><span style="font-family:'Times New Roman'; font-size:11pt"> and</span><span style="font-family:'Times New Roman'; font-size:11pt"> finally</span><span style="font-family:'Times New Roman'; font-size:11pt"> tau in a number of conditions (12).  How often, if ever, are an</span><span style="font-family:'Times New Roman'; font-size:11pt">y of these transmissible?  </span><span style="font-family:'Times New Roman'; font-size:11pt">The answer is likely to be rarely but is unlikely to be never.  As long ago as the 1960s, Rosalind Ridley and Harry Baker at the Clinical Research Centre in Harrow showed that, after an incubation period of 5 years, </span><span style="font-family:Symbol; font-size:11pt"></span><span style="font-family:Symbol; font-size:11pt"></span><span style="font-family:'Times New Roman'; font-size:11pt"> plaques (a pathological sign of Alzheimer’s Disease) were more abundant in the brains of marmosets that had been injected with Alzheimer’s brain matter than in a comparison group of control marmosets</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="17" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold; line-height:115%; margin:0pt 0pt 10pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Thus maint</span><span style="font-family:'Times New Roman'; font-size:11pt">e</span><span style="font-family:'Times New Roman'; font-size:11pt">n</span><span style="font-family:'Times New Roman'; font-size:11pt">ance of</span><span style="font-family:'Times New Roman'; font-size:11pt"> the UK’s capacity to research and</span><span style="font-family:'Times New Roman'; font-size:11pt"> to deal with </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> diseases, apart from representing prudent social readiness, also promises to be a resource that will contribute to understanding the prevention and treatment of much commoner neurological diseases and dementias</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">References</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 34.55pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Hilton DA, </span><span style="font-family:'Times New Roman'; font-size:11pt">Ghani</span><span style="font-family:'Times New Roman'; font-size:11pt"> AC, Conyers L, Edwards P, </span><span style="font-family:'Times New Roman'; font-size:11pt">McArdle</span><span style="font-family:'Times New Roman'; font-size:11pt"> L, Ritchie D et al. Prevalence of </span><span style="font-family:'Times New Roman'; font-size:11pt">lymphoreticular</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> protein accumulation in UK tissue samples</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">. J </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Pathol</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic"> </span><span style="font-family:'Times New Roman'; font-size:11pt">2004;203:733-9</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 21.3pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 34.55pt; orphans:0; padding-left:4.75pt; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">Gill ON et al. Prevalent abnormal </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> in human appendices after bovine spongiform encephalopathy epizootic; large scale survey. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">BMJ  </span><span style="font-family:'Times New Roman'; font-size:11pt">2013;347:f5675</span></li></ol><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 34.55pt; orphans:0; padding-left:4.75pt; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">The National CJD Research &amp; Surveillance Unit.  Twentieth annual report 2011. </span><span style="font-family:'Times New Roman'; font-size:11pt">Creutzfeldt</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">Jakob</span><span style="font-family:'Times New Roman'; font-size:11pt"> Disease S</span><span style="font-family:'Times New Roman'; font-size:11pt">urveillance in the UK. Edinburgh 2012. The National CJD Research &amp; Surveillance Unit [accessed 18 Sep 2013] available at </span><a href="http://www.cjd.ed.ac.uk/documents/report20.pdf"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.cjd.ed.ac.uk/documents/report20.pdf</span></a></li></ol><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 34.55pt; orphans:0; padding-left:4.75pt; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">Garske</span><span style="font-family:'Times New Roman'; font-size:11pt"> T, </span><span style="font-family:'Times New Roman'; font-size:11pt">Ghani</span><span style="font-family:'Times New Roman'; font-size:11pt"> AC. </span><span style="font-family:'Times New Roman'; font-size:11pt">Uncertainty in the ta</span><span style="font-family:'Times New Roman'; font-size:11pt">i</span><span style="font-family:'Times New Roman'; font-size:11pt">l of the variant Creutzfeldt-Jakob disease epidemic in the UK. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">PLoS</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic"> ONE </span><span style="font-family:'Times New Roman'; font-size:11pt">2010;5:e15626</span></li></ol><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Arial; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 35.47pt; padding-left:3.83pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Lloyd SE, Mead S, </span><span style="font-family:'Times New Roman'; font-size:11pt">Collinge</span><span style="font-family:'Times New Roman'; font-size:11pt"> J. Genetics of </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> diseases. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Current </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Opin</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic"> Genetic Dev</span><span style="font-family:'Times New Roman'; font-size:11pt"> 2013 June;23(3):345-51.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:11pt">&#xa0;</span></p><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 34.55pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Bruce ME, Will RG, </span><span style="font-family:'Times New Roman'; font-size:11pt">Ironside</span><span style="font-family:'Times New Roman'; font-size:11pt"> JW et al. </span><span style="font-family:'Times New Roman'; font-size:11pt">Transmission to mice indicates that new variant CJD is caused by the BSE agent. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Nature</span><span style="font-family:'Times New Roman'; font-size:11pt"> 1997;389:498-501</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="7" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 34.55pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Collinge</span><span style="font-family:'Times New Roman'; font-size:11pt"> J, Sidle KCL, Meads J, </span><span style="font-family:'Times New Roman'; font-size:11pt">Ironside</span><span style="font-family:'Times New Roman'; font-size:11pt"> J, Hill AF. Molecular analysis of </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> strain variation and the aetiology of "new variant" CJD. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Nature</span><span style="font-family:'Times New Roman'; font-size:11pt"> 1996;383:685-90</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="8" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 34.55pt; orphans:0; padding-left:4.75pt; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">Knight R. The risk of transmitting </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> disease by blood and plasma products. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Transfusion and </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Apheresis</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic"> Science </span><span style="font-family:'Times New Roman'; font-size:11pt">2010;</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">43:</span><span style="font-family:'Times New Roman'; font-size:11pt">387-91</span></li></ol><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="9" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 34.55pt; orphans:0; padding-left:4.75pt; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">Animal Health and Veterinary Laboratories Agency. Cattle TSE Surveillance Statistics [accessed 18 Sep 2013] available at </span><a href="http://www.defra.gov.uk/ahvla-en/files/pub-tse-stats-gboverview.pdf"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.defra.gov.uk/ahvla-en/files/pub-tse-stats-gboverview.pdf</span></a></li></ol><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="10" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 39.3pt; orphans:0; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">Guidance on prevention of CJD and </span><span style="font-family:'Times New Roman'; font-size:11pt">vCJD</span><span style="font-family:'Times New Roman'; font-size:11pt"> by Advisory Committee on Dangerous Pathogens' Transmissible Spongiform Encephalopathy (ACDP TSE) Risk Management Subgroup [accessed 18 Sep 2013] </span><span style="font-family:'Times New Roman'; font-size:11pt">available at </span><a href="https://www.gov.uk/government/publications/guidance-from-the-acdp-tse-risk-management-subgroup-formerly-tse-working-group"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">https://www.gov.uk/government/publications/guidance-from-the-acdp-tse-risk-management-subgroup-formerly-tse-</span><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">working-group</span></a></li></ol><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="11" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 39.3pt; orphans:0; text-align:justify; text-indent:0pt; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">Edgeworth</span><span style="font-family:'Times New Roman'; font-size:11pt"> JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T et al. </span><span style="font-family:'Times New Roman'; font-size:11pt">Detection of </span><span style="font-family:'Times New Roman'; font-size:11pt">prion</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">infection in variant Creutzfeldt-Jakob disease: a blood-based assay. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Lancet </span><span style="font-family:'Times New Roman'; font-size:11pt">2011;</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">377:</span><span style="font-family:'Times New Roman'; font-size:11pt">487-93</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="12" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 39.3pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Walker LC, </span><span style="font-family:'Times New Roman'; font-size:11pt">Jucker</span><span style="font-family:'Times New Roman'; font-size:11pt"> M. Seeds of dementia. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Sci</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic"> Am</span><span style="font-family:'Times New Roman'; font-size:11pt"> 2013;308(5)38-43</span></li></ol><p style="margin:0pt 0pt 0pt 39.3pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic; font-weight:bold">Declaration of interest</span></p><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">I am currently Board Member for Wales and Chair of the Welsh Food Advisory Committee for the Food Standards Agency and also a member of the Department of Health’s Advisory Committee on Dangerous Pathogens and of t</span><span style="font-family:'Times New Roman'; font-size:11pt">hat committee’s Spongiform Encephalopathy Sub Group.  I am a member of the </span><span style="font-family:'Times New Roman'; font-size:11pt">Conseil</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">d’Administration</span><span style="font-family:'Times New Roman'; font-size:11pt"> (Management Advisory Board) of the </span><span style="font-family:'Times New Roman'; font-size:11pt">Institut</span><span style="font-family:'Times New Roman'; font-size:11pt"> de </span><span style="font-family:'Times New Roman'; font-size:11pt">Veille</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">Sanitaire</span><span style="font-family:'Times New Roman'; font-size:11pt"> (French National Institute for Public Health Surveillance).</span></p><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; orphans:0; text-align:justify; widows:0"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">November 2013</span><a name="_GoBack"></a></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p></div></body></html>